21 August 2020 - Drug makers and their lobbyists are struggling to agree on a strategy that would convince President Trump to back off a highly controversial drug pricing policy that he vowed to enact on Monday.

This week, the group, the Pharmaceutical Research and Manufacturers of America convened three calls with member companies to discuss how to respond to an ultimatum that Trump laid out in July. 

He said then that the industry would have to come up with a way to significantly lower drug prices before 24 August, or his administration would enact a policy, despised by the industry, that would tie what the U.S. pays for drugs to what other countries pay.

Read Stat News article